SCHEMBL7653149

SCHEMBL7653149

CC(N)C(N)(Cc1ccccc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.56
HIF1A Q16665 1/20 0.56
SLC6A2 P23975 3/20 0.47
TAAR1 Q96RJ0 3/20 0.47
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.43
TRPA1 O75762 1/20 0.43
CYP3A4 P08684 1/20 0.43
RECQL P46063 1/20 0.43
ALPI P09923 1/20 0.43
PKM P14618 1/20 0.43
PTGS1 P23219 1/20 0.43
XIAP P98170 1/20 0.43
SLC7A5 Q01650 1/20 0.43
MAOA P21397 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
CYP2A6 P11509 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11265928 0.87 SMN1; SMN2 (0.58) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2
SCHEMBL28136599 0.87 SMN1; SMN2 (0.58) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2
SCHEMBL6981342 0.87 SMN1; SMN2 (0.58) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2
Hydrochloric Acid SCHEMBL17262536 0.86 SMN1; SMN2 (0.56) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2
SCHEMBL28189016 0.86 SMN1; SMN2 (0.56) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2
SCHEMBL28189019 0.86 SMN1; SMN2 (0.56) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2
SCHEMBL27962346 0.84 SMN1; SMN2 (0.55) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2
SCHEMBL9462605 0.83 SMN1; SMN2 (0.53) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2
SCHEMBL1274884 0.80 SMN1; SMN2 (0.58) SMN1; SMN2HIF1ASLC6A2TAAR1ALPI
SCHEMBL4551689 0.80 SMN1; SMN2 (0.58) SMN1; SMN2HIF1ASLC6A2TAAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358978-B1 FOR THERAPY AND PROPHYLAXIS OF RHEUMATOID ARTHRITIS (IN THE CASE OF INFLAMMATION), OSTEOARTHRITIS, ASTHMA, CARDIAC INFARCT, ALZHEIMER'S DISEASE, OR ATHEROSCLEROSIS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-03-19 US disclosed